HF
TRVI icon

HRT Financial’s Trevi Therapeutics TRVI Stock Holding History

HRT Financial’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$562K Buy
+30,146
New +$438K ﹤0.01% 2560
2026
Q1 		– Sell
-125,104
Closed -$1.57M – 4747
2025
Q4 		$1.57M Buy
+125,104
New +$1.45M ﹤0.01% 1452

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

HRT Financial's TRVI Position: Q2 2026 in Review

HRT Financial opened a new position in Trevi Therapeutics (TRVI) in Q2 2026: 30,146 shares worth $562K. The stake represents ﹤0.01% of the portfolio and ranks #2560 among its holdings. This is a return to the name: HRT Financial previously reported a position in TRVI as recently as Q4 2025.

HRT Financial first reported a position in TRVI in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.57M in Q4 2025. 218 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • HRT Financial held 30,146 shares of Trevi Therapeutics worth $562K as of Q2 2026.
  • Trevi Therapeutics was a new HRT Financial position in Q2 2026.
  • Trevi Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2560 holding.
  • HRT Financial first reported a position in Trevi Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • HRT Financial's Trevi Therapeutics position peaked at $1.57M in Q4 2025.
  • 218 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.